Revance Therapeutics Stock (NASDAQ: RVNC) stock price, news, charts, stock research, profile.
You can purchase shares of Revance Therapeutics (NASDAQ:RVNC) through any online brokerage.
Other companies in Revance Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH) and GH Research (NASDAQ:GHRS).
Revance Therapeutics has a consensus price target of $12.76.
The stock price for Revance Therapeutics (NASDAQ: RVNC) is $3.8 last updated November 25, 2024 at 5:28 PM EST.
There are no upcoming dividends for Revance Therapeutics.
Revance Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Revance Therapeutics.
Revance Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.